At the moment there are two KRAS inhibitors on the market, Krazati and Amgen’s Lumakras (sotorasib), which are ... combination with its own EGFR drug Vectibix (panitumumab).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback